BRN.AX BrainChip (ASX) closed A$0.145 on 11 Feb 2026: AI edge chip outlook and forecast

BRN.AX stock finished the ASX session at A$0.145 on 11 Feb 2026 after steady intraday trade between A$0.140 and A$0.150. Investors are watching BrainChip Holdings Ltd (ASX) for adoption of its Akida neuromorphic IP in low-power AI edge devices. Volume of 5,503,799 shares lifted liquidity but remains below the 50-day average. This note links financials, technicals and a model forecast to give an AI-sector perspective.

Market close snapshot and recent news on BRN.AX stock

BrainChip Holdings Ltd (BRN.AX) closed at A$0.145 on the ASX in Australia on 11 Feb 2026. The stock traded with a day low of A$0.140 and a day high of A$0.150, while year range sits between A$0.130 and A$0.325. Volume for the session was 5,503,799 versus an average volume of 9,290,175, signalling below-average turnover.

Recent coverage includes technical and market summaries from MarketBeat and technical indicator updates on Investing.com. The ASX listing and product pipeline remain the primary drivers for trading moves.

BRN.AX stock: Financials, valuation and key ratios

BrainChip reports EPS of -0.02 and a trailing PE shown as -7.5, reflecting ongoing losses as it scales product development. Market capitalisation stands at A$353,768,742.00 with shares outstanding 2,358,458,279. Price averages are 50-day A$0.1703 and 200-day A$0.19648, indicating the stock trades below medium-term trend levels.

Key ratios show a high price-to-sales of 190.43 and price-to-book of 14.49, signalling market expectations for future growth but also valuation risk. The current ratio of 5.18 and cash per share A$0.00647 support a multi-quarter runway, but operating margins remain negative at -17.03%.

Technical picture and trading signals for BRN.AX stock

Momentum indicators are mixed: RSI is 60.30, the CCI is 137.05, and the MFI is 86.99, which together point to short-term strength with overbought readings. Bollinger Bands sit at Upper A$0.19, Middle A$0.17, Lower A$0.15, suggesting limited immediate upside without heavier volume.

On balance, the stock shows near-term momentum but lacks a clear trend (ADX 19.05). Traders should watch the 50-day average A$0.1703 and 200-day average A$0.19648 as resistance levels and monitor volume since average daily volume remains higher than current flows.

Meyka AI rates BRN.AX with a score out of 100 and model forecast

Meyka AI rates BRN.AX with a score of 64.90 out of 100 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade is informational and not financial advice.

Meyka AI’s forecast model projects a 12-month target of A$0.166 compared with the current price of A$0.145, implying an upside of 14.65%. Monthly and quarterly model points are A$0.11 and A$0.09 respectively. Forecasts are model-based projections and not guarantees.

Analyst view, price targets and BRN.AX stock outlook

Analyst sentiment is mixed with limited formal coverage and no consensus price target published. We present three realistic scenarios: conservative target A$0.09, base case A$0.17, and upside case A$0.32 which equals the 52-week high.

The base case relies on modest revenue traction for Akida IP and stable cash burn. The upside requires OEM design wins and faster adoption in automotive or cybersecurity use cases. The conservative scenario assumes slower adoption and dilution pressure.

Risks, opportunities and fit in an AI equities strategy

Primary risks are continued negative earnings, valuation stretch, and execution risk for hardware partners. Financially, BrainChip’s operating margins and negative EPS highlight ongoing funding needs. Debt metrics are low (debt-to-equity 0.07), which helps near-term solvency.

Opportunities include rising demand for low-power AI edge chips and potential licensing revenue for Akida. For AI-focused portfolios, BRN.AX stock is a speculative small-cap growth exposure best sized modestly and monitored for design wins and cash runway updates. See our detailed page on Meyka for live metrics: Meyka BRN.AX stock page.

Final Thoughts

BRN.AX stock closed at A$0.145 on 11 Feb 2026 with mixed technical signals and above-average short-term interest. Financial metrics show negative EPS -0.02, high price-to-sales 190.43, and cash per share of A$0.00647, which together underline both growth potential and valuation risk. Meyka AI’s model projects a 12-month price of A$0.166, implying 14.65% upside from current levels; this assumes steady adoption of Akida IP and modest revenue growth. Risk scenarios include slower design wins and further capital raises that dilute shareholders. For AI portfolio strategies, treat BRN.AX as a high-volatility, speculative holding and size positions accordingly. Forecasts are model-based projections and not guarantees. For ongoing news and technical updates see MarketBeat and Investing.com.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.